Skip to main content
OpenTrials
Completed

NCT Number: NCT01169831

Regulation of Endothelial Progenitor Cells by Short-Term Exercise

Endothelial Progenitor Cells (EPCs) are circulating cells released from bone marrow which are important for maintaining cardiovascular health. The prevalence of cardiovascular disease in older adults is associated with reduced circulating EPC numbers. Studies have shown reduced EPC number and function in old vs. young individuals, and endurance exercise training increases EPC number and function in young adults. Oxidative stress adversely affects endothelial cells and preliminary evidence indicates that oxidative stress negatively affects EPC function. Conversely, regular exercise reduces markers of oxidative stress and may enhance EPC function in older adults. The investigators hypothesize that older endurance-trained athletes and matched sedentary individuals will have markedly divergent EPC function and that altering the physical activity levels of both groups will move them to intermediate points between these two extremes. The investigators also propose that the investigators can "mimic" the effect of exercise training on EPC function in cell culture by altering intracellular levels of a key enzyme and a signaling molecule which the investigators have shown to regulate EPC function with respect to exercise training in young individuals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Maryland, Baltimore & Baltimore VA Medical Center

Baltimore, Maryland, 21201, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 50-80 years of age, BMI = 18-35 kg/m2, non-smoking, women must be postmenopausal

Exclusion criteria

  • history of cardiovascular/cerebrovascular disease, diabetes, cancer, renal, liver disease, HIV; uncontrolled hyperlipidemia/hypertension

Treatment and study plan

Exercise training

Other

2 weeks of daily aerobic exercise training

Exercise Cessation

Other

Stopping all exercise for 2 weeks

Primary outcomes

  1. Baseline Endothelial progenitor cell number

    Time frame: Day 1

  2. Final Endothelial Progenitor Cell Number

    Time frame: Day 15

Secondary outcomes

  1. Baseline Endothelial Reactivity

    Time frame: Day 1

  2. Final Endothelial Reactivity

    Time frame: Day 15

Sponsors and collaborators

Lead sponsor

Baltimore VA Medical Center

Fed

Collaborators

  • University of Maryland, Baltimore
  • University of Maryland, College Park

Registry information

Acronym: EPC-Ex

Important dates

Study start
2011
Primary completion
2014
Study completion
2024
First posted
Jul 26, 2010
Registry last updated
Aug 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.